Shopping Cart
- Remove All
- Your shopping cart is currently empty
SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.1It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50= 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50= 5.33 μM) but not cathepsin B when used at a concentration of 20 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $95 | 35 days | |
5 mg | $365 | 35 days | |
10 mg | $688 | 35 days | |
25 mg | $1,480 | 35 days |
Description | SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.1It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50= 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50= 5.33 μM) but not cathepsin B when used at a concentration of 20 μM. 1.() |
Alias | SSAA09E1 |
Molecular Weight | 199.3 |
Formula | C7H9N3S2 |
Cas No. | 433212-75-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.